See product citations (13)
QUICK LINKS
WEB-2086 (Apafant) is a platelet activating factor receptor (PAF-R) antagonist shown to have anticancer and cell differentiation effects. It has been found to be a specific PAF-R antagonist in pulmonary vasculature and when administered intratracheally in rats. WEB-2086 was observed to decrease lung nuclear factor-kappaB (NF-kappaB) activation, myeloperoxidase activity, and lavage neutrophil numbers. It may act to be a cytodifferentiating agent in murine erythroleukemia cells in vitro. WEB-2086 inhibited cell growth and hemoglobin accumulation and also contains antiproliferative properties.
Ordering Information
Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
WEB-2086, 1 mg | sc-201007 | 1 mg | $100.00 | |||
WEB-2086, 5 mg | sc-201007A | 5 mg | $163.00 |